Haemonetics Corp expected to post earnings of 89  cents a share - Earnings Preview

Haemonetics

31/10/2023 10:03

* Haemonetics Corp  HAE.N   HAE  is expected to show a rise
in
quarterly revenue when it reports  results on November 2. 
    * The Boston Massachusetts-based  company is expected to
report  a
5.3% increase in revenue to $313.119 million from $297.49
million a year ago, according to the mean estimate from 6
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Haemonetics Corp is
for
earnings of 89 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Haemonetics
Corp
is $112​, above​ its last closing price of $84.92. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2023  0.72        0.73       1.05      Beat    43.7
 Mar. 31 2023  0.72        0.70       0.77      Beat    9.2
 Dec. 31 2022  0.83        0.80       0.85      Beat    5.9​
 Sep. 30 2022  0.68        0.67       0.83      Beat    23.2
 ​​Jun.        0.51        0.51       0.58      Beat    13.6
 30 2022                                                
 Mar. 31 2022  0.60        0.60       0.65      Beat    8.2​
 Dec. 31 2021  0.73        0.73       0.84      Beat    14.4
 Sep. 30 2021  0.61        0.61       0.60      Missed  -1
 This summary was machine generated October 31 at 10:02 GMT.  All
figures in US dollars  unless otherwise stated